-
Something wrong with this record ?
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia
MN. Dworzak, B. Buldini, G. Gaipa, R. Ratei, O. Hrusak, D. Luria, E. Rosenthal, JP. Bourquin, M. Sartor, A. Schumich, L. Karawajew, E. Mejstrikova, O. Maglia, G. Mann, WD. Ludwig, A. Biondi, M. Schrappe, G. Basso, International-BFM-FLOW-network,
Language English Country United States
Document type Journal Article
Grant support
NV15-28525A
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Free Medical Journals
from 2002
Medline Complete (EBSCOhost)
from 2012-03-01 to 1 year ago
Wiley Free Content
from 2003 to 1 year ago
PubMed
28187514
DOI
10.1002/cyto.b.21518
Knihovny.cz E-resources
- MeSH
- Precursor Cell Lymphoblastic Leukemia-Lymphoma diagnosis MeSH
- Acute Disease MeSH
- Child MeSH
- Phenotype MeSH
- Immunophenotyping standards MeSH
- Consensus MeSH
- Humans MeSH
- Flow Cytometry standards MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
Immunophenotyping by flow cytometry (FCM) is a worldwide mainstay in leukemia diagnostics. For concordant multicentric application, however, a gap exists between available classification systems, technologic standardization, and clinical needs. The AIEOP-BFM consortium induced an extensive standardization and validation effort between its nine national reference laboratories collaborating in immunophenotyping of pediatric acute lymphoblastic leukemia (ALL). We elaborated common guidelines which take advantage of the possibilities of multi-color FCM: marker panel requirements, immunological blast gating, in-sample controls, tri-partite antigen expression rating (negative vs. weak or strong positive) with capturing of blast cell heterogeneities and subclone formation, refined ALL subclassification, and a dominant lineage assignment algorithm able to distinguish "simple" from bilineal/"complex" mixed phenotype acute leukemia (MPAL) cases, which is essential for choice of treatment. These guidelines are a first step toward necessary inter-laboratory standardization of pediatric leukemia immunophenotyping for a concordant multicentric application. © 2017 International Clinical Cytometry Society.
Clinic for Oncology and Tumor Immunology HELIOS Klinikum Berlin Buch Berlin Germany
Department of Pediatric Oncology Hematology Charité Universitätsmedizin Berlin Germany
Department of Pediatrics University Medical Center Schleswig Holstein Kiel Germany
Laboratory of Pediatric Onco Hematology Women and Child Department University of Padova Padova Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028806
- 003
- CZ-PrNML
- 005
- 20201022094905.0
- 007
- ta
- 008
- 190813s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/cyto.b.21518 $2 doi
- 035 __
- $a (PubMed)28187514
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Dworzak, Michael N $u Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
- 245 10
- $a AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia / $c MN. Dworzak, B. Buldini, G. Gaipa, R. Ratei, O. Hrusak, D. Luria, E. Rosenthal, JP. Bourquin, M. Sartor, A. Schumich, L. Karawajew, E. Mejstrikova, O. Maglia, G. Mann, WD. Ludwig, A. Biondi, M. Schrappe, G. Basso, International-BFM-FLOW-network,
- 520 9_
- $a Immunophenotyping by flow cytometry (FCM) is a worldwide mainstay in leukemia diagnostics. For concordant multicentric application, however, a gap exists between available classification systems, technologic standardization, and clinical needs. The AIEOP-BFM consortium induced an extensive standardization and validation effort between its nine national reference laboratories collaborating in immunophenotyping of pediatric acute lymphoblastic leukemia (ALL). We elaborated common guidelines which take advantage of the possibilities of multi-color FCM: marker panel requirements, immunological blast gating, in-sample controls, tri-partite antigen expression rating (negative vs. weak or strong positive) with capturing of blast cell heterogeneities and subclone formation, refined ALL subclassification, and a dominant lineage assignment algorithm able to distinguish "simple" from bilineal/"complex" mixed phenotype acute leukemia (MPAL) cases, which is essential for choice of treatment. These guidelines are a first step toward necessary inter-laboratory standardization of pediatric leukemia immunophenotyping for a concordant multicentric application. © 2017 International Clinical Cytometry Society.
- 650 _2
- $a akutní nemoc $7 D000208
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a průtoková cytometrie $x normy $7 D005434
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunofenotypizace $x normy $7 D016130
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a akutní lymfatická leukemie $x diagnóza $7 D054198
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Buldini, Barbara $u Laboratory of Pediatric Onco-Hematology, Women and Child Department, University of Padova, Padova, Italy.
- 700 1_
- $a Gaipa, Giuseppe $u Tettamanti Research Center and Department of Pediatrics, Ospedale San Gerardo, University of Milano-Bicocca, Monza, Italy.
- 700 1_
- $a Ratei, Richard $u Clinic for Oncology and Tumor Immunology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.
- 700 1_
- $a Hrusak, Ondrej $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Luria, Drorit $u Department of Pediatric Hematology and Oncology, Schneider's Children's Medical Center, Petach-Tikva, Israel.
- 700 1_
- $a Rosenthal, Eti $u Cancer Research Center and the Hematology Laboratory, Jeffrey Modell Foundation (JMF) Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
- 700 1_
- $a Bourquin, Jean-Pierre $u Division of Oncology and Children's Research Center, University Children's Hospital, University of Zurich, Zurich, Switzerland.
- 700 1_
- $a Sartor, Mary $u Flow Cytometry Unit, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, Australia.
- 700 1_
- $a Schumich, Angela $u Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Karawajew, Leonid $u Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin, Berlin, Germany.
- 700 1_
- $a Mejstrikova, Ester $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Maglia, Oscar $u Tettamanti Research Center and Department of Pediatrics, Ospedale San Gerardo, University of Milano-Bicocca, Monza, Italy.
- 700 1_
- $a Mann, Georg $u Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Ludwig, Wolf-Dieter $u Clinic for Oncology and Tumor Immunology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.
- 700 1_
- $a Biondi, Andrea $u Tettamanti Research Center and Department of Pediatrics, Ospedale San Gerardo, University of Milano-Bicocca, Monza, Italy.
- 700 1_
- $a Schrappe, Martin $u Department of Pediatrics, University Medical Center Schleswig-Holstein, Kiel, Germany.
- 700 1_
- $a Basso, Giuseppe $u Laboratory of Pediatric Onco-Hematology, Women and Child Department, University of Padova, Padova, Italy.
- 710 2_
- $a International-BFM-FLOW-network
- 773 0_
- $w MED00013936 $t Cytometry. Part B, Clinical cytometry $x 1552-4957 $g Roč. 94, č. 1 (2018), s. 82-93
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28187514 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20201022094902 $b ABA008
- 999 __
- $a ok $b bmc $g 1433955 $s 1067266
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 94 $c 1 $d 82-93 $e 20170221 $i 1552-4957 $m Cytometry. Part B, Clinical cytometry $n Cytometry B Clin Cytom $x MED00013936
- GRA __
- $a NV15-28525A $p MZ0
- LZP __
- $a Pubmed-20190813